Henry Chen
Amministratore Delegato presso Curamir Therapeutics, Inc.
Profilo
Henry Chen is the founder and currently serves as the Managing Partner at Delos Advisors Ltd., a company he founded in 2014.
He is also the founder and Chief Executive Officer of Curamir Therapeutics, Inc., which is established in 2019.
In addition to his founding positions, Mr. Chen previously held the role of Chief Executive Officer at Tanvex BioPharma USA, Inc. from 2020 to 2021.
Prior to that, he was a Partner & Co-Head at Permira Advisers (China) Ltd.
from 2008 to 2014.
Mr. Chen obtained his undergraduate degree from Harvard Law School in 1996.
Posizioni attive di Henry Chen
| Società | Posizione | Inizio |
|---|---|---|
Curamir Therapeutics, Inc.
 Curamir Therapeutics, Inc. BiotechnologyHealth Technology Curamir Therapeutics, Inc. engages in the provision of biotechnology company specializing in micro RNA (miRNA) based cancer therapeutics. The company was founded by Henry Chen, Jingfang Ju, James D. Watson, and Lan Bo Chen and is headquartered in Woburn, MA. | Amministratore Delegato | 01/01/2019 |
Delos Advisors Ltd.
 Delos Advisors Ltd. Investment ManagersFinance Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong. | Fondatore | 01/12/2014 |
Precedenti posizioni note di Henry Chen
| Società | Posizione | Fine |
|---|---|---|
| Tanvex BioPharma USA, Inc. | Amministratore Delegato | 01/10/2021 |
| Permira Advisers (China) Ltd. | Public Communications Contact | 01/12/2014 |
Formazione di Henry Chen
| Harvard Law School | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
| Tanvex BioPharma USA, Inc. | |
| Permira Advisers (China) Ltd. | Finance |
Delos Advisors Ltd.
Delos Advisors Ltd. Investment ManagersFinance Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong. | Finance |
Curamir Therapeutics, Inc.
Curamir Therapeutics, Inc. BiotechnologyHealth Technology Curamir Therapeutics, Inc. engages in the provision of biotechnology company specializing in micro RNA (miRNA) based cancer therapeutics. The company was founded by Henry Chen, Jingfang Ju, James D. Watson, and Lan Bo Chen and is headquartered in Woburn, MA. | Health Technology |
- Borsa valori
- Insiders
- Henry Chen
